CareDx, Inc (CDNA)
USD 20.4
(-7.86%)
USD 20.4
(-7.86%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 178.32 Million USD | -16.09% |
| 2022 | 209.58 Million USD | 5.31% |
| 2021 | 199 Million USD | 54.18% |
| 2020 | 129.07 Million USD | 58.16% |
| 2019 | 81.61 Million USD | 87.26% |
| 2018 | 43.58 Million USD | 61.7% |
| 2017 | 26.95 Million USD | 38.16% |
| 2016 | 19.5 Million USD | 9.17% |
| 2015 | 17.87 Million USD | -4.76% |
| 2014 | 18.76 Million USD | 44.12% |
| 2013 | 13.02 Million USD | 3.99% |
| 2012 | 12.52 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 54.67 Million USD | -13.17% |
| 2024 Q2 | 63.7 Million USD | 40.06% |
| 2024 Q1 | 45.48 Million USD | 15.69% |
| 2023 Q1 | 51.29 Million USD | -3.02% |
| 2023 Q2 | 44.41 Million USD | -13.42% |
| 2023 Q4 | 39.31 Million USD | -7.84% |
| 2023 Q3 | 42.65 Million USD | -3.95% |
| 2023 FY | 175.86 Million USD | -16.09% |
| 2022 Q4 | 52.89 Million USD | 3.6% |
| 2022 FY | 209.58 Million USD | 5.31% |
| 2022 Q1 | 52.53 Million USD | 0.6% |
| 2022 Q2 | 53.09 Million USD | 1.07% |
| 2022 Q3 | 51.05 Million USD | -3.84% |
| 2021 FY | 199 Million USD | 54.18% |
| 2021 Q1 | 45.82 Million USD | 15.25% |
| 2021 Q4 | 52.21 Million USD | 2.89% |
| 2021 Q3 | 50.75 Million USD | 1.07% |
| 2021 Q2 | 50.21 Million USD | 9.59% |
| 2020 Q2 | 26.77 Million USD | 3.03% |
| 2020 FY | 129.07 Million USD | 58.16% |
| 2020 Q1 | 25.98 Million USD | 12.48% |
| 2020 Q4 | 39.75 Million USD | 8.77% |
| 2020 Q3 | 36.55 Million USD | 36.52% |
| 2019 Q4 | 23.1 Million USD | 3.53% |
| 2019 Q2 | 19.94 Million USD | 22.73% |
| 2019 FY | 81.61 Million USD | 87.26% |
| 2019 Q1 | 16.24 Million USD | 24.99% |
| 2019 Q3 | 22.31 Million USD | 11.91% |
| 2018 Q4 | 13 Million USD | 5.72% |
| 2018 FY | 43.58 Million USD | 61.7% |
| 2018 Q3 | 12.29 Million USD | 15.83% |
| 2018 Q2 | 10.61 Million USD | 38.43% |
| 2018 Q1 | 7.66 Million USD | 10.92% |
| 2017 Q1 | 6.2 Million USD | 41.65% |
| 2017 FY | 26.95 Million USD | 38.16% |
| 2017 Q4 | 6.91 Million USD | -0.97% |
| 2017 Q3 | 6.98 Million USD | 1.82% |
| 2017 Q2 | 6.85 Million USD | 10.6% |
| 2016 Q2 | 4.85 Million USD | 28.21% |
| 2016 Q1 | 3.79 Million USD | -8.94% |
| 2016 FY | 19.5 Million USD | 9.17% |
| 2016 Q3 | 6.51 Million USD | 34.1% |
| 2016 Q4 | 4.37 Million USD | -32.83% |
| 2015 Q1 | 4.5 Million USD | -21.62% |
| 2015 FY | 17.87 Million USD | -4.76% |
| 2015 Q4 | 4.16 Million USD | -9.19% |
| 2015 Q3 | 4.58 Million USD | -0.82% |
| 2015 Q2 | 4.62 Million USD | 2.57% |
| 2014 FY | 18.76 Million USD | 44.12% |
| 2014 Q2 | 4.37 Million USD | 16.24% |
| 2014 Q4 | 5.74 Million USD | 17.74% |
| 2014 Q3 | 4.88 Million USD | 11.64% |
| 2014 Q1 | 3.76 Million USD | 6.81% |
| 2013 Q3 | 3.3 Million USD | -1.05% |
| 2013 Q1 | 2.85 Million USD | 0.0% |
| 2013 FY | 13.02 Million USD | 3.99% |
| 2013 Q2 | 3.33 Million USD | 16.84% |
| 2013 Q4 | 3.52 Million USD | 6.63% |
| 2012 FY | 12.52 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Bionano Genomics, Inc. | 9.56 Million USD | -1764.154% |
| Prenetics Global Limited | 8.82 Million USD | -1919.562% |
| Star Equity Holdings, Inc. | 11.92 Million USD | -1395.262% |
| Exact Sciences Corporation | 1.84 Billion USD | 90.337% |
| Exagen Inc. | 29.45 Million USD | -505.394% |
| Inotiv, Inc. | 165.44 Million USD | -7.786% |
| Guardant Health, Inc. | 336.89 Million USD | 47.068% |
| Biodesix, Inc. | 36.07 Million USD | -394.29% |
| BioNexus Gene Lab Corp. | 1.32 Million USD | -13312.957% |
| Precipio, Inc. | 6.01 Million USD | -2863.194% |
| iSpecimen Inc. | 5.1 Million USD | -3391.15% |
| Natera, Inc. | 492.74 Million USD | 63.81% |
| Aspira Women's Health Inc. | 5.26 Million USD | -3288.921% |
| Standard BioTools Inc. | 50.45 Million USD | -253.469% |
| 23andMe Holding Co. | 99.37 Million USD | -79.443% |
| Castle Biosciences, Inc. | 174.8 Million USD | -2.013% |
| Personalis, Inc. | 18.2 Million USD | -879.377% |
| Aclaris Therapeutics, Inc. | 13.16 Million USD | -1254.23% |
| Applied DNA Sciences, Inc. | 5.53 Million USD | -3122.683% |
| OpGen, Inc. | -90.69 Thousand USD | 196722.709% |
| T2 Biosystems, Inc. | -8.17 Million USD | 2282.681% |
| Myriad Genetics, Inc. | 476.4 Million USD | 62.568% |
| ICON Public Limited Company | 1.81 Billion USD | 90.171% |
| NeoGenomics, Inc. | 244.6 Million USD | 27.096% |
| Star Equity Holdings, Inc. | 11.92 Million USD | -1395.262% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | 91.857% |
| RadNet, Inc. | 93 Million USD | -91.747% |
| MDxHealth SA | 43.92 Million USD | -305.939% |
| Psychemedics Corporation | 8.41 Million USD | -2019.636% |
| Illumina, Inc. | 2.74 Billion USD | 93.501% |
| Check-Cap Ltd. | -212 Thousand USD | 84215.566% |
| Twist Bioscience Corporation | 133.34 Million USD | -33.728% |
| DarioHealth Corp. | 5.98 Million USD | -2880.03% |
| Fulgent Genetics, Inc. | 104.45 Million USD | -70.718% |
| Sera Prognostics, Inc. | 96 Thousand USD | -185655.208% |
| ENDRA Life Sciences Inc. | -275.45 Thousand USD | 64839.282% |
| OPKO Health, Inc. | 318.12 Million USD | 43.945% |
| Medpace Holdings, Inc. | 524.5 Million USD | 66.001% |
| Neogen Corporation | 463.9 Million USD | 61.56% |
| Intelligent Bio Solutions Inc. | 1.42 Million USD | -12408.54% |
| Prenetics Global Limited | 8.82 Million USD | -1919.562% |
| Mainz Biomed B.V. | 509.65 Thousand USD | -34889.081% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -22426.733% |
| Trinity Biotech plc | 19.45 Million USD | -816.838% |
| Neuronetics, Inc. | 51.7 Million USD | -244.889% |
| Sotera Health Company | 577.15 Million USD | 69.103% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -22426.733% |